(Q45286357)

English

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

scientific article published on 4 September 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

hospitalization

1 reference

based on heuristic

inferred from title

0 references

cerebrovascular disease

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Joan Puig-barberà

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Javier Diez-Domingo

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Germán Schwarz-Chavarri

4

object named as

Germán Schwarz Chavarri

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Angel Belenguer Varea

3

object named as

Angel Belenguer Varea

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

David González Vidal

7

object named as

David González Vidal

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

José A Lluch Rodrigo

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Santiago Pérez Hoyos

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

4 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

7313-7321

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Influenza-associated hospitalizations in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza and the winter increase in mortality in the United States, 1959-1999.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza-associated mortality in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Ageing and infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

The "case-control" study: valid selection of subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Principles for modeling propensity scores in medical research: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

What Does the Odds Ratio Estimate in a Case-Control Study?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Proportion of disease caused or prevented by a given exposure, trait or intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza vaccination and the risk of primary cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Association of influenza vaccination and reduced risk of recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Association between influenza vaccination and reduced risk of brain infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza vaccination is associated with a reduced risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Evidence of bias in estimates of influenza vaccine effectiveness in seniors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Autoimmune nature of influenza atherogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

The role of infection and immunity in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.039

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.08.039

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

release_bdukjt35xzcabh2iwhy6a6zrmi

1 reference

https://api.fatcat.wiki/v0/release/bdukjt35xzcabh2iwhy6a6zrmi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45286357&oldid=2073596967"